United Therapeutics Corp. (UTHR)
587.50
+2.71
(+0.46%)
USD |
NASDAQ |
Oct 23, 16:00
587.82
+0.32
(+0.05%)
After-Hours: 20:00
United Therapeutics Price to Book Value : 3.917 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.917 |
| October 22, 2026 | 3.899 |
| October 21, 2026 | 3.757 |
| October 20, 2026 | 3.693 |
| October 19, 2026 | 3.622 |
| October 16, 2026 | 3.555 |
| October 15, 2026 | 3.611 |
| October 14, 2026 | 3.601 |
| October 13, 2026 | 3.623 |
| October 12, 2026 | 3.668 |
| October 09, 2026 | 3.662 |
| October 08, 2026 | 3.552 |
| October 07, 2026 | 3.634 |
| October 06, 2026 | 3.612 |
| October 05, 2026 | 3.577 |
| October 02, 2026 | 3.612 |
| October 01, 2026 | 3.810 |
| September 30, 2026 | 3.613 |
| September 29, 2026 | 3.210 |
| September 28, 2026 | 3.238 |
| September 25, 2026 | 3.170 |
| September 24, 2026 | 3.149 |
| September 23, 2026 | 3.263 |
| September 22, 2026 | 3.318 |
| September 21, 2026 | 3.288 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.298 |
| September 17, 2026 | 3.316 |
| September 16, 2026 | 3.324 |
| September 15, 2026 | 3.336 |
| September 14, 2026 | 3.352 |
| September 11, 2026 | 3.315 |
| September 10, 2026 | 3.360 |
| September 09, 2026 | 3.379 |
| September 08, 2026 | 3.320 |
| September 04, 2026 | 3.251 |
| September 03, 2026 | 3.269 |
| September 02, 2026 | 3.281 |
| September 01, 2026 | 3.419 |
| August 31, 2026 | 3.403 |
| August 28, 2026 | 3.437 |
| August 27, 2026 | 3.520 |
| August 26, 2026 | 3.445 |
| August 25, 2026 | 3.458 |
| August 24, 2026 | 3.420 |
| August 21, 2026 | 3.422 |
| August 20, 2026 | 3.474 |
| August 19, 2026 | 3.528 |
| August 18, 2026 | 3.456 |
| August 17, 2026 | 3.390 |
| August 14, 2026 | 3.332 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 19.48 |
| MannKind Corp. | -- |
| Gilead Sciences, Inc. | 16.37 |
| Insmed, Inc. | 26.91 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
Price to Book Value Related Metrics
| PE Ratio | 21.01 |
| PS Ratio | 8.735 |
| PEG Ratio | 2.293 |
| Price to Free Cash Flow | 25.42 |
| Price | 587.50 |
| Earnings Yield | 4.76% |
| Market Cap | 25.07B |
| PEGY Ratio | 2.293 |
| Operating PE Ratio | 19.63 |
| Normalized PE Ratio | 22.52 |